Elevance Health (ELV) Shares Repurchased (2010 - 2026)

Elevance Health (ELV) has 16 years of Shares Repurchased data on file, last reported at $1.1 billion in Q1 2026.

• Quarterly Shares Repurchased rose 27.73% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 billion (down 11.36% YoY) and the FY2025 annual result came in at $2.6 billion, down 10.17% from the prior year.
• Shares Repurchased advanced to $1.1 billion in Q1 2026 per ELV's latest filing, from $471.0 million in the prior quarter.
• Across five years, Shares Repurchased topped out at $1.8 billion in Q4 2024 and bottomed at $60.0 million in Q3 2024.
• The 5-year median for Shares Repurchased is $579.0 million (2022), against an average of $683.6 million.
• The widest annual swing landed in 2024, when Shares Repurchased tumbled 87.5%; it then soared 1360.0% in 2025.
• Tracing ELV's Shares Repurchased over 5 years: stood at $568.0 million in 2022, then soared by 63.38% to $928.0 million in 2023, then jumped by 95.15% to $1.8 billion in 2024, then tumbled by 73.99% to $471.0 million in 2025, then soared by 138.64% to $1.1 billion in 2026.
• Per Business Quant, the three latest ELV Shares Repurchased figures stand at $1.1 billion (Q1 2026), $471.0 million (Q4 2025), and $876.0 million (Q3 2025).

Peer Comparison